TROY, N.Y., Feb. 26, 2026 /PRNewswire/ — The specialty medication experience often feels confusing and fragmented, with little clarity into where a prescriptionTROY, N.Y., Feb. 26, 2026 /PRNewswire/ — The specialty medication experience often feels confusing and fragmented, with little clarity into where a prescription

Levrx Brings Clarity to the Specialty Medication Journey

2026/02/27 04:45
3 min read

TROY, N.Y., Feb. 26, 2026 /PRNewswire/ — The specialty medication experience often feels confusing and fragmented, with little clarity into where a prescription is or what is happening. This uncertainty stems from a complex system where specialty medications are routed through specialty pharmacies and savings solutions selected by employers, PBMs, and health plans.

Levrx® is addressing this gap with the new Specialty Marketplace Lever.

The Levrx platform serves as the experience layer across a client’s pharmacy benefit strategy. The Specialty Marketplace Lever is not another point solution and does not replace specialty pharmacies or clinical programs. Instead, it is embedded within the Levrx platform, reflecting a client’s chosen vendors and workflows while giving members access to specialty information alongside their broader pharmacy benefit details.

As specialty strategies become more dynamic, prescriptions often move between prescribers, specialty pharmacies, and additional programs operating in parallel. Without a centralized view, members are left navigating multiple touchpoints without clear guidance. Even short gaps in information can create frustration and uncertainty, particularly when medications are high cost or clinically critical.

The Specialty Marketplace Lever brings structure to that experience by centralizing specialty visibility within the Levrx platform. Members can see which pharmacy is managing their medication, where their prescription stands, and what steps come next. When multiple vendors or programs are part of the strategy, they are reflected together within a single, guided journey rather than as disconnected touchpoints.

At the same time, the experience remains configurable based on client strategy and down to the plan level. Specialty pharmacy relationships and additional programs can be structured according to each sponsor’s design, recognizing that not every group within a book of business requires the same solution.

Specialty Marketplace within the Levrx platform becomes an added lever within an already best in class pharmacy navigation and engagement platform, giving members one place to go for their pharmacy benefit and related solutions while preserving strategic flexibility for sponsors.

By reducing uncertainty and unnecessary outreach, Specialty Marketplace lowers frustration, supports operational efficiency, and builds trust during some of the most sensitive moments in the pharmacy journey.

About Levrx: Levrx is a healthcare technology company that serves as the pharmacy navigation and engagement hub for members, employers, health plans, and PBMs. Its digital platform brings structure, transparency, and coordination to complex pharmacy experiences, helping members understand what is happening and what to expect while delivering measurable value across the pharmacy ecosystem. Learn more at www.levrx.com.

Media Contact:

Natalia Robinson
[email protected] 
518.629.1440

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/levrx-brings-clarity-to-the-specialty-medication-journey-302698955.html

SOURCE Levrx Technology

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

WTI jumps above $70.50 on fears of Iran supply disruption

WTI jumps above $70.50 on fears of Iran supply disruption

The post WTI jumps above $70.50 on fears of Iran supply disruption appeared on BitcoinEthereumNews.com. West Texas Intermediate (WTI), the US crude oil benchmark
Share
BitcoinEthereumNews2026/03/02 09:44
BlackRock boosts AI and US equity exposure in $185 billion models

BlackRock boosts AI and US equity exposure in $185 billion models

The post BlackRock boosts AI and US equity exposure in $185 billion models appeared on BitcoinEthereumNews.com. BlackRock is steering $185 billion worth of model portfolios deeper into US stocks and artificial intelligence. The decision came this week as the asset manager adjusted its entire model suite, increasing its equity allocation and dumping exposure to international developed markets. The firm now sits 2% overweight on stocks, after money moved between several of its biggest exchange-traded funds. This wasn’t a slow shuffle. Billions flowed across multiple ETFs on Tuesday as BlackRock executed the realignment. The iShares S&P 100 ETF (OEF) alone brought in $3.4 billion, the largest single-day haul in its history. The iShares Core S&P 500 ETF (IVV) collected $2.3 billion, while the iShares US Equity Factor Rotation Active ETF (DYNF) added nearly $2 billion. The rebalancing triggered swift inflows and outflows that realigned investor exposure on the back of performance data and macroeconomic outlooks. BlackRock raises equities on strong US earnings The model updates come as BlackRock backs the rally in American stocks, fueled by strong earnings and optimism around rate cuts. In an investment letter obtained by Bloomberg, the firm said US companies have delivered 11% earnings growth since the third quarter of 2024. Meanwhile, earnings across other developed markets barely touched 2%. That gap helped push the decision to drop international holdings in favor of American ones. Michael Gates, lead portfolio manager for BlackRock’s Target Allocation ETF model portfolio suite, said the US market is the only one showing consistency in sales growth, profit delivery, and revisions in analyst forecasts. “The US equity market continues to stand alone in terms of earnings delivery, sales growth and sustainable trends in analyst estimates and revisions,” Michael wrote. He added that non-US developed markets lagged far behind, especially when it came to sales. This week’s changes reflect that position. The move was made ahead of the Federal…
Share
BitcoinEthereumNews2025/09/18 01:44
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication

XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication

– XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea’s National Health Insurance Service (NHIS) for the treatment of adult patients with
Share
AI Journal2026/03/02 09:15